SAN MATEO, Calif., Dec. 19 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced that Steven Basta, Chief Executive Officer, will present a company overview at the upcoming 26th Annual JPMorgan Healthcare Conference being held from January 7-10, 2008. BioForm Medical's presentation will take place on Monday, January 7th, 2008 at 8:30 a.m. PST (11:30 am EST) at the Westin St. Francis Hotel in San Francisco, CA.
A live and archived copy of the webcast of BioForm Medical's presentation will be available on the Investor Relations section of the company's website at http://www.bioform.com. Participants should allow adequate time prior to the event to download any software necessary for the webcast.
About BioForm Medical, Inc.:
BioForm Medical, Inc. is a medical aesthetics company headquartered in San Mateo, California. BioForm Medical is dedicated to bringing doctors and their patients safe and effective products for use in the dermatology, plastic surgery and ENT markets. BioForm Medical's products include Radiesse(R) filler for use in facial aesthetics and vocal fold insufficiency, and Coaptite(R) injectable implant for treating female stress urinary incontinence which is marketed through a partnership with Boston Scientific Corporation. BioForm Medical has licensed U.S. marketing rights to Aethoxysklerol(R) sclerotherapy agent, which is the leading worldwide sclerotherapy agent and is currently being evaluated in a Phase III clinical trial. BioForm Medical has also licensed BioGlue(R) surgical adhesive product for plastic surgery applications, which is being developed in a partnership with CryoLife, Inc.
This press release contains forward-looking statements within the
meaning of the U.S. Private Securities Litigation Reform Act of 1995.
Specifically, statements concerning BioForm Medical's ability to continue
to grow demand for Radiesse and likelihood and timing of future product
introductions are forward-looking statements within the meaning of the Safe
Harbor. Forward-looking statements are based on management's current,
preliminary expectations and are subject to risks and uncertainties, which
may cause BioForm Medical's actual results to differ materially from the
statements contained herein. Further information on potential risk factors
that could affect BioForm Medical's business and its financial results are
detailed in its prospectus as filed with the Securities and Exchange
Commission on November 6, 2007. Undue reliance should not be placed on
forward-looking statements, especially guidance on future financial
performance, which speaks only as of the date they are made. BioForm
Medical undertakes no obligation to update publicly any forward-looking
statements to reflect new information, events or circumstances after the
date they were made, or to reflect the occurrence of unanticipated events.
Vice President, Corporate Development
BioForm Medical, Inc.
|SOURCE BioForm Medical, Inc.|
Copyright©2007 PR Newswire.
All rights reserved